RxDoctor Payments Data

Christopher Ketcham, DO

Physical Medicine & Rehabilitation · South Bend, INNPI 1780098780

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 28.7% of the total.

$1,649in general payments, 2019–2025

Across 76 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$472
  • Ipsen Biopharmaceuticals, Inc$445
  • Avanir Pharmaceuticals, Inc.$120
  • Merz North America, Inc.$114
  • Merz Pharmaceuticals, LLC$92
  • Amgen$86
  • plus $320 from 12 others

What the payments were for

  • Food & beverage$1,649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,649 in reported general payments places this provider in the 75th percentile of 140 physical medicine & rehabilitation providers in Indiana.

See all physical medicine & rehabilitation providers in Indiana

Medicare billing

Part B allowed, 2024
$245,044
Medicare patients
395
Services billed
25,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen342$5,924
Pregabalin78$3,859
Gabapentin361$3,681
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen145$2,258
Tramadol Hcl159$972
Tizanidine Hcl70$942
Oxycodone Hcl126$895
Morphine Sulfate86$811
Amitriptyline Hcl33$647
Methocarbamol17$493
Methylphenidate Hcl12$330
Carbidopa-LevodopaCarbidopa/Levodopa12$238
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$218
Ropinirole Hcl24$134
Escitalopram Oxalate16$58

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →